EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets

Lizz van der Heijden iD, Geert Spierenburg, Joseph K Kendal, Nicholas M Bernthal, Michiel A J van de Sande iD

Journal of Surgical Oncology · 2023

DOI: 10.1002/jso.27410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Lizz van der Heijden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenosynovial giant cell tumor (TGCT) is a rare, benign, locally aggressive synovial based neoplastic process that can result in functional debilitation and end‐stage arthrtitis. Although surgical resection is the primary treatment modality, novel systemic therapies are emerging as part of the multimodal armamentarium for patients with unresectable or complex disease burden. This review discusses the pathogenesis of TGCT, potential druggable targets and therapeutic approaches. It also evaluates the safety and efficacy of different systemic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell Tumor of Tendon SheathGiant Cell TumorsHumans

Stichwörter der Autor:innen

CSF1CSF1Rcolony-stimulating factor 1colony-stimulating factor 1 receptordrug developmentdrug targetssystemic therapytenosynovial giant cell tumor

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Pediatric Orthopedic Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Department of Orthopedic Surgery, University of California-Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Lizz van der Heijden, Michiel A J van de Sande

Zitieren

APA

van der Heijden, L., Spierenburg, G., Kendal, J. K., Bernthal, N. M., & van de Sande, M. A. J. (2023). Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27410

Vancouver

van der Heijden L, Spierenburg G, Kendal JK, Bernthal NM, van de Sande MAJ. Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27410

BibTeX
@article{vanderHeijden2023,
  author = {van der Heijden, Lizz and Spierenburg, Geert and Kendal, Joseph K and Bernthal, Nicholas M and van de Sande, Michiel A J},
  title = {Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  doi = {10.1002/jso.27410}
}
Kostenlos starten →